[SYRS] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
06-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 52.78%
YoY- 17.40%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 7,802 5,697 5,162 4,827 5,699 3,828 3,188 81.30%
PBT -23,813 -26,027 -22,490 -14,228 -30,130 -19,486 -17,196 24.16%
Tax 986 984 969 967 1,417 0 0 -
NP -23,813 -26,027 -22,490 -14,228 -30,130 -19,486 -17,196 24.16%
Tax Rate - - - - - - - -
Total Cost 31,615 31,724 27,652 19,055 35,829 23,314 20,384 33.88%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -305.22 -456.85 -435.68 -294.76 -528.69 -509.04 -539.40 -31.51%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -3.78 -4.14 -3.60 -2.32 -4.91 -4.26 -3.76 0.35%
EPS Diluted -3.78 -4.14 -3.58 -2.32 -4.91 -4.26 -3.76 0.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.